For: | Méndez-Sánchez N, Bermejo-Martínez LB, Viñals Y, Chavez-Tapia NC, Graff IV, Ponciano-Rodríguez G, Ramos MH, Uribe M. Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects. World J Gastroenterol 2005; 11(39): 6182-6187 [PMID: 16273647 DOI: 10.3748/wjg.v11.i39.6182] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i39/6182.htm |
Number | Citing Articles |
1 |
S. N. Wang, Y. T. Yeh, M. L. Yu, C. Y. Dai, W. C. Chi, W. L. Chung, K. T. Lee. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. European Journal of Clinical Investigation 2006; 36(3): 176 doi: 10.1111/j.1365-2362.2006.01611.x
|
2 |
Nahum Mendez-Sanchez, Norberto C. Chavez-Tapia, Misael Uribe. Pregnancy and gallbladder disease. Annals of Hepatology 2006; 5(3): 227 doi: 10.1016/S1665-2681(19)32018-6
|
3 |
Peter Kovacs, Ulrike Kurtz, Henning Wittenburg. Hepatic insulin resistance ties cholesterol gallstone formation and the metabolic syndrome. Annals of Hepatology 2008; 7(3): 262 doi: 10.1016/S1665-2681(19)31861-7
|
4 |
Shatakshi Srivastava, Ravindra Kumar. Is hyperleptinemia associated with gallstone disease? A systematic review and meta-analysis. Indian Journal of Gastroenterology 2023; 42(3): 324 doi: 10.1007/s12664-022-01332-6
|
5 |
Dagfinn Aune, Lars J. Vatten. Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies. Journal of Diabetes and its Complications 2016; 30(2): 368 doi: 10.1016/j.jdiacomp.2015.11.012
|
6 |
Laura M. Stinton, Eldon A. Shaffer. Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer. Gut and Liver 2012; 6(2): 172 doi: 10.5009/gnl.2012.6.2.172
|
7 |
И. Н. Григорьева, Т. Е. Нотова, Т. С. Суворова, Ю. В. Чикинев, Г. Н. Толстых, Д. Л. Непомнящих, Н. Л. Тов, Т. И. Романова. Характеристики артериальной гипертензии у больных желчнокаменной болезнью в сочетании с сахарным диабетом 2 типа. Ateroscleroz 2023; 19(3): 203 doi: 10.52727/2078-256X-2023-19-3-203-205
|
8 |
Henning Wittenburg. Hereditary liver disease: Gallstones. Best Practice & Research Clinical Gastroenterology 2010; 24(5): 747 doi: 10.1016/j.bpg.2010.07.004
|
9 |
Wendy Campos-Perez, Mariana Perez-Robles, Roberto Rodriguez-Echevarria, Juan J. Rivera-Valdés, Fernando M. Rodríguez-Navarro, Edgar A. Rivera-Leon, Erika Martinez-Lopez. High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study. Clinics and Research in Hepatology and Gastroenterology 2022; 46(3): 101802 doi: 10.1016/j.clinre.2021.101802
|
10 |
Serdar Saraç, Aytaç Atamer, Yildiz Atamer, Ahmet Selçuk Can, Aslan Bilici, İbrahim Taçyildiz, Yüksel Koçyiğit, Necati Yenice. Leptin levels and lipoprotein profiles in patients with cholelithiasis. Journal of International Medical Research 2015; 43(3): 385 doi: 10.1177/0300060514561134
|
11 |
Nahum Méndez-Sánchez, Luisa Bermejo-Martínez, Norberto C. Chávez-Tapia, Daniel Zamora-Valdés, Karla Sánchez-Lara, Martha H. Uribe-Ramos, Guadalupe Ponciano-Rodríguez, Hector A. Baptista-González, Martha H. Ramos, Misael Uribe. Obesity-related leptin receptor polymorphisms and gallstones disease. Annals of Hepatology 2006; 5(2): 97 doi: 10.1016/S1665-2681(19)32025-3
|
12 |
Antonio Ramos-De la Medina, José M. Remes-Troche, Federico B. Roesch-Dietlen, Alfonso G. Pérez-Morales, Silvia Martinez, Silvia Cid-Juarez. Routine Liver Biopsy to Screen for Nonalcoholic Fatty Liver Disease (NAFLD) during Cholecystectomy for Gallstone Disease: Is it Justified?. Journal of Gastrointestinal Surgery 2008; 12(12): 2097 doi: 10.1007/s11605-008-0704-7
|
13 |
Norberto C. Chávez-Tapia, Misael Uribe, Guadalupe Ponciano-Rodríguez, Roberto Medina-Santillán, Nahum Méndez-Sánchez. New insights into the pathophysiology of nonalcoholic fatty liver disease. Annals of Hepatology 2009; 8: S9 doi: 10.1016/S1665-2681(19)31821-6
|
14 |
N. A. Cherkashchenko, M. A. Livzan, T. S. Krolevets. Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2020; 92(2): 48 doi: 10.26442/00403660.2020.02.000550
|
15 |
Ruxandra Mare, Ioan Sporea. Gastrointestinal and Liver Complications in Patients with Diabetes Mellitus—A Review of the Literature. Journal of Clinical Medicine 2022; 11(17): 5223 doi: 10.3390/jcm11175223
|
16 |
T.S. Krolevets, M.A. Livzan, M.I. Syrovenko. Liver fibrosis in nonalcoholic fatty liver disease: the role of adipokines and noninvasive assessment of the intestinal barrier. Dokazatel'naya gastroenterologiya 2023; 12(2): 46 doi: 10.17116/dokgastro20231202146
|
17 |
Weigen Wu, Yuchen Pei, Junlong Wang, Qizhi Liang, Wei Chen. Association between visceral lipid accumulation indicators and gallstones: a cross-sectional study based on NHANES 2017–2020. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02319-2
|
18 |
Chen Jing, Zhengyi Wang, Xue Fu. Effect of diabetes mellitus on survival in patients with gallbladder Cancer: a systematic review and meta-analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07139-y
|
19 |
Lanlan Chen, Hongqun Yang, Haitao Li, Chang He, Liu Yang, Guoyue Lv. Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study. Hepatology 2022; 75(4): 785 doi: 10.1002/hep.32183
|